Ceballos Kirtley, Waterman Kari, Hulett Teresa, Makic Mary Beth Flynn
Neonatal Intensive Care Unit, University of Colorado Hospital, Denver, CO 80045, USA.
Adv Neonatal Care. 2013 Jun;13(3):154-63; quiz 164-5. doi: 10.1097/ANC.0b013e318285fe70.
Hospital-acquired infections are a leading cause of morbidity and mortality in neonatal intensive care units. Central line-associated blood stream infection (CLABSI) and ventilator-associated pneumonia (VAP) are costly, preventable infections targeted for eradication by the Centers for Disease Control and Prevention. After evaluation of current practice and areas for improvement, neonatal-specific CLABSI and VAP bundles were developed and implemented on the basis of available best evidence. The overall goal was to reduce infection rates at or below benchmarks set by National Healthcare Safety Network. All neonates with central lines (umbilical or percutaneous) and/or patients who were endotracheally intubated were included. All patients were risk stratified on the basis of weight per National Healthcare Safety Network reporting requirements: less than 750 g, 751-1000 g, 1001-1500 g, 1501-2500 g, and greater than 2500 g. The research was conducted as a quality improvement study. Neonatal-specific educational modules were developed by neonatal nurse leaders for CLABSI and VAP. Bundle development entailed combining select interventions, mainly from the adult literature, that the nurse leaders believed would reduce infection rates. Nursing practice guidelines and supply carts were updated to ensure understanding, compliance, and convenience. A CLABSI checklist was initiated and used at the time of line insertion by the nurse to ensure standardized infection control practices. Compliance audits were performed by nurse leaders weekly on intubated patients to validate VAP bundle implementation. CLABSI and VAP bundle compliance was audited and infection rates were measured before and after both bundle implementations following strict National Healthcare Safety Network inclusion criteria for CLABSI and VAP determination. The reduction in CLABSI elicited 84 fewer hospital days, estimated cost savings of $348,000, a 92% reduction in CLABSI (preintervention to postintervention), and a reduction in central line days by 27%. The reduction in VAP resulted in 72 fewer hospital days, estimated cost savings of $300,000, 71% reduction in VAP (preintervention to postintervention), and a reduction in vent days by 31%. Nurses are central in hospital efforts to improve quality care. The bundled interventions provided the nurses with a structure to successfully implement a systematic process for improvement. Nursing leaders ensured that bundles were implemented strategically and provided consistent and specific feedback on intervention compliance with quarterly CLABSI and VAP rates. Real-time feedback assisted the registered nurses, neonatal nurse practitioners, and physicians appreciation of the effectiveness of the change in practice. Finally, empowering the bedside nurse to lead the bundle implementation increased personal ownership and compliance and ultimately improved practice and patient outcomes.
医院获得性感染是新生儿重症监护病房发病和死亡的主要原因。中心静脉导管相关血流感染(CLABSI)和呼吸机相关性肺炎(VAP)是代价高昂且可预防的感染,疾病控制与预防中心致力于消除此类感染。在评估当前做法和改进领域后,根据现有最佳证据制定并实施了针对新生儿的CLABSI和VAP集束化干预措施。总体目标是将感染率降低至或低于国家医疗安全网络设定的基准。纳入所有置有中心静脉导管(脐静脉或经皮)的新生儿和/或气管插管患者。所有患者根据国家医疗安全网络报告要求按体重进行风险分层:小于750克、751 - 1000克、1001 - 1500克、1501 - 2500克以及大于2500克。该研究作为一项质量改进研究开展。新生儿护士组长针对CLABSI和VAP开发了特定于新生儿的教育模块。集束化干预措施的制定需要整合主要来自成人文献的精选干预措施,护士组长认为这些措施可降低感染率。更新了护理实践指南和供应推车,以确保理解、合规和便利。启动了CLABSI检查表,护士在置管时使用,以确保标准化的感染控制措施。护士组长每周对插管患者进行合规性审核,以验证VAP集束化干预措施的实施情况。按照国家医疗安全网络关于CLABSI和VAP判定的严格纳入标准,在实施这两种集束化干预措施前后,对CLABSI和VAP集束化干预措施的合规情况进行审核,并测量感染率。CLABSI感染率的降低使住院天数减少了84天,估计节省成本34.8万美元,CLABSI感染率降低了92%(干预前至干预后),中心静脉导管留置天数减少了27%。VAP感染率的降低使住院天数减少了72天,估计节省成本30万美元,VAP感染率降低了71%(干预前至干预后),呼吸机使用天数减少了31%。护士在医院改善优质护理的努力中起着核心作用。集束化干预措施为护士提供了一个结构,使其能够成功实施系统的改进流程。护理领导确保集束化干预措施得到战略性实施,并就干预措施的合规情况以及每季度的CLABSI和VAP感染率提供一致且具体的反馈。实时反馈有助于注册护士、新生儿护士执业医师和医生认识到实践改变的有效性。最后,赋予床边护士领导集束化干预措施实施的权力增加了个人责任感和合规性,最终改善了实践和患者结局。